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To assess the Qossibilify to detect viable myoc 
persistent defects at 20:TI-SP A 
h6xadecanoi&acicf, a new radiolabefled fatty acid), 24 patients (23 M, 1 F, 58 
f 9.7 y.o.) were prospectively studied between the 2nd and th 
following the onset of a first acute Q waves myocardiaf infarction ( 
All of them benefit of : stress 201TI-SPECT (3 mCi I.W. at t 
exercise, initial study and delayed study 4 hours later were petformed), st 
r23i-RMIHA-SPECT (4 mCi I.V. at the peak of exercise ; initial study 
delayed 40 min later) coronary angiography and left ventriculography. 
For both SPECT, short axis, sagittal and coronat images were reconstructed. 
The left wentricular myoca in 9 segments (sgts) to compare 
201Tl-SPECT with ‘231.WI and in 5 sgts (apical, anterior, se 
lateral, inferior) to compare with left ve~~~u~gra~hy. 
Of the 216 sgts anal 
reversible defects (R) 
delayed) was observe 
and in 121 (99.2%) of 
Of the 120 sgts analyse 
akinetic (A) and 16 hypokinetic (f-f). Preserved fixation of 201 TI was 
observed in 4 (25%) A sgts and in 3 (16.75%) H sgts , OiWHA kal~on was 
observed in9 (56,25%) of A sgts and in 8 (50%) of H sgts). 
To conclude, 1231-6MIHA appears to be usefull to detect viable myocardium 
in the area of a persistent defect at 20lTLSPECT in pa?ient with a first 
myocardial infarction without needing the use of a medical cyclotron. 
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We have previously shown that dobutamine echocardiography (DE) 
predicts functional recovery following thrombolysis for myocardial 
infarction (MI). Forty-five pts receiving thrombolysis for Ml uLticrwcot 
cardiac catheterization with analysis of the RAO contrast veorriculogram 
for post-cxtrasystolic potcntiation (PESP) &cr a paced or spontaneous 
premature contraction and low-dose DE (4 mcg/kg/min) 522 days after 
MI. Three me&ods wcrc used to predict functional rrcovcry of tbc infarct 
zone (IZ): 1) an increase in I2 wall motion aod wall thickening during low- 
dose DE, 2) a peak creatine kinase (CK) < 1000 IU. god 3) PESP of 
segmental wall motion of the 12. The preseoce or absence of rccovcry of 
regional systolic fuoctioo in the I2 was dcrcrmincd by 20 
cchocardiography 48~12 days after MI. Nineteen pts demonstrated 
functional recovery al follow-up. Sensitivity (SN’ specdicity (SP). aod 
accuracy (AC) of the 3 Iho to predict re e as follows: 
TEST DE ES!? DE+ E t PESP 
SN8 84 53 53 100 !OO 
SP% 88 88 72 77 h2 
AC% 87 78 64 87 79 
We conclude: 1) DE is the most accurate method 10 determine functional 
recovery after thrombolysis for acute MI. 2) CK c 1000 IU an& PESP have 
moderate specificity, but poor scositivity to predict recovery, and 3) 611 pts 
whodcmoostratedfunc~iooal recovery could be idenGficd by a combiaalion 
of DE and cithcr CK or PESP. 
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OF VWTRICU DYSFUNCTION AFTEX ACUTE 
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IntervenCions aimed at limitation of infarct size and/or 
infarce expansion frequently hely on measurements of LV 
function to asses9 their efficacy. However, several 
determinants of EV function (e.g. loading conditions) arta 
labile during tthe peri-infarction period. This study 
examines the effects of acute loading changes on global 
and regional LV function after completed MI. Eight 
s tudie in 6 patients were done 1827 (SE) days after 
acute I with tine computed tomography. Short axis 
movies were obtained using 8 mm slices, at 50 msec/frame, 
using non-ionic contrast. Global and regional mass, 
ejection fraction and volumes were obtained as previously 
described using Simpson’s rule for reconstruction. 
Loading was altered by administration of 0.3 to 0.6 mg 
sublingual nitroglycerin (NTG). NTG lowered systolic 
blood pressure from L24+,6 to 10724 mmHg* (*pCO.Ol), 
raised HR from 5824 to 62 2 4*, lowered end-diastolic 
volume from 358+,14 to 144fl3 ml* and increased global 
ejection fraction from 53+,3 to 56+3%*. The measured 
extent of systolic dysfunction (% of LV mass with akine- 
sis or hypokinesis) decreased by 2258%X followiwg NTG. 
Areas of the myocardium with significant dysfunction at 
baseline normalized with only a modest preload reduction. 
Conclusioq: Changes in the size and degree of regional 
dysfunction purported to result from an intervention, can 
be mimicked by simple loading changes. Studies which 
claim salutary effects of am intervention by citing 
improvement in global or regional function as evidence 
for a mural structural preservation (e.g. “salvage”), 
must take subtle differences in loading into account. 
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The aim of this study was to determine whether 
treatment with intravenous streptokinase [SK] with or 
ivithout oral aspirin [A] during acute infarction [MI] 
reduces the incidence of inducible ventricular tachy 
cardia [VT] at electrophysiologic study [EP]. 
Of 159 patients randomized at Westmead pita! to 
the placebo controlled, multicentre ISIS-2 s of SK 
and A in MI, 87 underwent EP 6.28 days later for 
prognostic reasons to determine their risk of late 
spontaneous VT. AlI 4 groups were clinically similar [SK 
20; A 25; SK + A 21; both placebo 211. Using s 4 
extrastimuli, only VT of cycle length 1 230ms of 1 10s 
n was considered abnormal. 
was induced in 8 of 46 patients treated with 
SK versus none of 41 treated with active Sk [p 
= O.OOS], and in 4 of 41 patients treated with pl 
versus 4 of 46 treated with active A [p = NS] 
mean follow-up 39 2 9 mon 
active SK had spontaneous l?d 
with placebo SK [p = 0.131. 
SK therapy for MI markedly reduces the Incidence 01 
inducible VT in infarct survivors. A has no such effect. 
